Samjin Pharm

Seoul, South Korea Founded: 1972 • Age: 54 yrs
Developing therapies for the treatment of HIV, cancer and neurodegenerative diseases
Request Access

About Samjin Pharm

Samjin Pharm is a company based in Seoul (South Korea) founded in 1972.. The company has 809 employees as of December 31, 2024.

  • Headquarter Seoul, South Korea
  • Employees 809 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Samjin Pharmaceutical Co., Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics → →
Key Metrics
  • Annual Revenue
    $209.08 M (USD)
    5.55
    as on Dec 31, 2024
  • Net Profit
    $26.6 M (USD)
    107.49
    as on Dec 31, 2024
  • EBITDA
    $33.25 M (USD)
    35.8
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    809

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Samjin Pharm

Samjin Pharm is a publicly listed company on the KRX with ticker symbol 005500 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 005500 . Sector: Health technology · South Korea

Funding Insights of Samjin Pharm

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Investments & Acquisitions by Samjin Pharm

Investments
Company Name Description Domain Location Founded Year Amount
Bento Cloud
Bionic investment advisor platform
2016
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Samjin Pharm

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Samjin Pharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Samjin Pharm

Company Name Domain Founded year HQ Location Description
inDrive
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
Bolt
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
Gojek
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
Dunzo
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Samjin Pharm

Frequently Asked Questions about Samjin Pharm

When was Samjin Pharm founded?

Samjin Pharm was founded in 1972.

Where is Samjin Pharm located?

Samjin Pharm is headquartered in Seoul, South Korea.

Who is the current CEO of Samjin Pharm?

Sung-Woo Lee is the current CEO of Samjin Pharm.

How many employees does Samjin Pharm have?

As of Dec 31, 2024, the latest employee count at Samjin Pharm is 809.

What is the annual revenue of Samjin Pharm?

Annual revenue of Samjin Pharm is $209.08M as on Dec 31, 2024.

What does Samjin Pharm do?

Samjin Pharm was founded in 1972 and is based in Seoul, South Korea. Therapies targeting HIV, cancer, and neurodegenerative diseases are developed by the company. Its lead candidate, SA001, is currently in phase II trials for dry eye syndrome treatment. Clinical development services are also provided, encompassing drug synthesis, toxicological studies, formulation laboratory work, and process development for new synthesis methods.

Is Samjin Pharm publicly traded?

Yes, Samjin Pharm is publicly traded on KRX under the ticker symbol 005500.

What is Samjin Pharm's ticker symbol?

The ticker symbol of Samjin Pharm is 005500 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available